Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/07/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 606 publications

Caffeine-Associated Reduction in Patent Ductus Arteriosus (PDA) is Mediated in Part by Adenosine Receptor Antagonism.

Caffeine-Associated Reduction in Patent Ductus Arteriosus (PDA) is Mediated in Part by Adenosine Receptor Antagonism.

Journal: American journal of physiology. Heart and circulatory physiology
Published: October 30, 2025

Methylxanthines: The Major Impact of Caffeine in Clinical Practice in Patients Diagnosed with Apnea of Prematurity.

Methylxanthines: The Major Impact of Caffeine in Clinical Practice in Patients Diagnosed with Apnea of Prematurity.

Journal: Journal of clinical medicine
Published: October 05, 2025

Recurrence of apnea of prematurity following early discontinuation of caffeine: A prospective analytical study.

Recurrence of apnea of prematurity following early discontinuation of caffeine: A prospective analytical study.

Journal: Journal of neonatal-perinatal medicine
Published: September 23, 2025

Risk Factors Associated with Postnatal Growth Velocity in Preterm Infants in a Tertiary Hospital in Northeast Mexico.

Risk Factors Associated with Postnatal Growth Velocity in Preterm Infants in a Tertiary Hospital in Northeast Mexico.

Journal: Journal of clinical medicine
Published: August 09, 2025

Gastroesophageal reflux and apnea in the preterm infant.

Gastroesophageal reflux and apnea in the preterm infant.

Journal: Seminars in perinatology
Published: July 30, 2025

Oral doxapram for apnea of prematurity: A randomized dosage trial.

Oral doxapram for apnea of prematurity: A randomized dosage trial.

Journal: Journal of perinatology : official journal of the California Perinatal Association
Published: July 15, 2025

Polygraphic Results in High-Risk Infants Aged Under 3 Months.

Polygraphic Results in High-Risk Infants Aged Under 3 Months.

Journal: Clocks & sleep
Published: July 09, 2025

Vibrating mesh nebulizers vs. less invasive surfactant administration in the treatment of preterm respiratory distress syndrome: a multicenter, open-label, exploratory, randomized clinical trial.

Vibrating mesh nebulizers vs. less invasive surfactant administration in the treatment of preterm respiratory distress syndrome: a multicenter, open-label, exploratory, randomized clinical trial.

Journal: European journal of medical research
Published: June 09, 2025

What is the Role of Caffeine in the Management of Preterm Infants?

What is the Role of Caffeine in the Management of Preterm Infants?

Journal: Current treatment options in pediatrics
Published: April 28, 2025

Extended Caffeine for Apnea in Moderately Preterm Infants: The MoCHA Randomized Clinical Trial.

Extended Caffeine for Apnea in Moderately Preterm Infants: The MoCHA Randomized Clinical Trial.

Journal: JAMA
Published: April 28, 2025

Cumulative caffeine exposure predicts neurodevelopmental outcomes in premature infants.

Cumulative caffeine exposure predicts neurodevelopmental outcomes in premature infants.

Journal: Pediatric research
Published: April 17, 2025

Nasal DUOPAP vs nasal continuous positive airway pressure in preterm neonates with respiratory distress syndrome - A randomized control trial.

Nasal DUOPAP vs nasal continuous positive airway pressure in preterm neonates with respiratory distress syndrome - A randomized control trial.

Journal: Early human development
Published: February 18, 2025
Showing 1-12 of 606

Last Updated: 01/07/2026